Family Integration in Therapy Activities in the Intensive Care Unit: The FIT-ICU Feasibility Study (FIT-ICU)

January 2, 2024 updated by: Kimberley Lewis, St. Joseph's Healthcare Hamilton

An ICU admission is stressful for not only patients but their families as well. Research has shown that involving family members during a loved one's ICU stay can be helpful for them, but there is not clear direction on the best way to do this. For patients, family presence as well as early movement during their ICU stay has been shown to help recovery from things like delirium (a state of confusion) faster, and might prevent the weakness that can happen with a stay in the ICU. In this study, the investigators will explore whether having family help with moving patients through physiotherapy guided exercise can help both patients and families have a better experience and result from their ICU stay.

The investigators hypothesize that family involvement in activities as part of an overall physiotherapy treatment plan will provide a tangible means for family members to engage in the care of their critically ill loved one, thus improving outcomes for both critically ill patients and family members.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8N 4A6
        • Recruiting
        • St Joseph's Healthcare Hamilton
        • Principal Investigator:
          • Kimberley Lewis, MD
        • Contact:
        • Sub-Investigator:
          • Laiya Carayannopoulos, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults (≥18 years) in the ICU
  • Anticipated length of stay ≥48 hours for whom a request for physiotherapy has been placed by the treating physician
  • Appropriateness for physiotherapy confirmed by the unit's physiotherapist.
  • Families will be eligible if they are able to be present in ICU during physiotherapist or research team work hours until they are cleared to deliver activities independently, then at least three times weekly thereafter.

Exclusion Criteria:

  • Patients who are receiving end of life care
  • Patients who have high risk injuries including spinal cord injury or spinal fractures, post-operative from spinal surgery, and untreated hip or long bone fractures
  • Patients at risk of raised intracranial pressure (ICP) (e.g. Malignant middle cerebral artery stroke, large subarachnoid hemorrhage), admitted post trauma activation, post-operative from brain surgery or with external ventricular drain (EVD) in situ.
  • Patients who are bed-bound or require mechanical lift at baseline who would not otherwise be offered physiotherapy services.
  • Exclusion criteria for families include any major barriers to participation, i.e., physical, cognitive, emotional or capacity to understand and communicate with the team.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: All participants
Patients to receive mobility interventions from trained family members
Family delivery of mobility activities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility - consent rate
Time Frame: Study duration - up to one year
We define a successful consent rate as > 70% of SDMs or patients approached to consent, agreeing to take part in the study
Study duration - up to one year
Feasibility - recruitment rate
Time Frame: Study duration - up to one year
We define a successful recruitment rate as achieving enrolment of four patients per month over the duration of the trial
Study duration - up to one year
Feasibility - protocol adherence
Time Frame: During ICU stay, censored at 1 month
We define successful adherence as average family involvement in ≥ 3 sessions/week. Furthermore, adherence to documentation of involvement will be successful if documented by family for ≥80% of sessions
During ICU stay, censored at 1 month
Feasibility - resources
Time Frame: Study duration - up to one year
Physiotherapist and nurse outcomes will include inability to train families due to physiotherapy or team resources, and number of sessions per week cancelled due to inadequate staffing resources during the patients ICU stay.
Study duration - up to one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Delirium
Time Frame: During ICU stay, censored at 1 month
CAM-ICU
During ICU stay, censored at 1 month
Patient & Family PTSD symptoms
Time Frame: 1 & 3 months
IES-R
1 & 3 months
Adverse Events
Time Frame: During ICU stay, censored at 1 month
Falls, hypotension, bradycardia, line removal, unplanned extubation, inappropriate family intervention, unexpected injuries
During ICU stay, censored at 1 month
Family satisfaction
Time Frame: 1 & 3 months
23-item Family Satisfaction in the ICU questionnaire; HADS scale
1 & 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2023

Primary Completion (Estimated)

April 30, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

September 19, 2023

First Submitted That Met QC Criteria

October 4, 2023

First Posted (Actual)

October 6, 2023

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 2, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 15669

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Clinical Trials on Family involvement

3
Subscribe